Visual hallucinatory syndromes: Past, present, and future

Dialogues in Clinical Neuroscience

Volumn 9, Issue 2, 2007, Pages 173-189

  Ffytche, Dominic H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acetylcholine; Charles Bonnet syndrome; Deafferentation; Lilliputian hallucination; Mental automatism; Neurophenomenology; Serotonin; Visual hallucination; Zoopsia

Indexed keywords

ACETAZOLAMIDE; ACETYLCHOLINE; ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINESTERASE INHIBITOR; CISAPRIDE; NEUROLEPTIC AGENT; SEROTONIN; SEROTONIN ANTAGONIST;

ARTICLE; AUTOMATISM; CHARLES BONNET SYNDROME; CHOLINERGIC TRANSMISSION; CLINICAL FEATURE; DEAFFERENTATION; DRUG RESEARCH; EYE DISEASE; EYE SURGERY; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; MIGRAINE; NEUROSCIENCE; PARKINSON DISEASE; PERCEPTION DISORDER; SEROTONINERGIC SYSTEM; VISION; VISUAL HALLUCINATION; VISUAL SYSTEM;

BRAIN; BRAIN DISEASES; HALLUCINATIONS; HISTORY, 20TH CENTURY; HUMANS; MODELS, NEUROLOGICAL; NEUROLOGY; NEUROTRANSMITTER AGENTS; VISUAL PATHWAYS;

EID: 34447556635     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. de Morsier G. Les automatismes visuels. (Hallucinations visuelles rétrochiasmatiques). Schweizerische Medizinische Wochenschr. 1936;66:700-703.
2. L'Hermitte J, De Ajuriaguerra J. Hallucinations visuelles et lésions de l'appareil visuel. Ann Médico-Psychologique. s 1936;94 i:321-351.
3. Catani M, ffytche DH. The rises and falls of disconnection syndromes. Brain. 2005;128:2224-2239.
4. Heuyer G. G. G. de Clérambault. Encéphale. 1950;39:413-439.
5. Ey H. Une théorie méchaniciste: la doctrine de G. de Clérambault. Études Psychiatriques. Paris: Desclée de Brouwer; 1948.
6. de Morsier G. Le Mécanisme des hallucinations. Ann Médico-Psychologiques. 1930;88:365-389.
7. de Morsier G. Les Hallucinations: étude Oto-neuro- ophtalmologique. Rev Oto-Neuro-Ophtalmol. 1938;16:244-352.
8. ffytche DH, Catani M. Beyond localisation: from hodology to function. Phil Trans R Soc. Lon B. 2005;360:767-779.
9. Seguin EC. A clinical study of lateral hemianopsia. J Nerv Ment Dis. 1886;13:445-454.
10. Shipp S. Corticopulvinar connections of areas V5, V4, and V3 in the macaque monkey: a dual model of retinal and cortical topographies. J Comp Neurol. 2001;439:469-490.
11. Starobinski J. Georges de Morsier (1894-1982). Gesnerus. 1983;40:335-338.
12. Uchida H, Suzuki T, Tanaka KF, Watanabe K, Yagi G, Kashima H. Recurrent episodes of perceptual alteration in patients treated with antipsychotic agents. J Clin Psychopharmacol. 2003;23:496-499.
13. Uchida H, Suzuki T, Watanabe K, Yagi G, Kashima H. Antipsychotic-induced paroxysmal perceptual alteration. Am J Psychiatry. 2003;160:2243-2244.
14. ffytche DH. Visual hallucinations and the Charles Bonnet Syndrome. Curr Psychiatr Reports. 2005;7:168-179.
15. Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci. 2005;28:737-57; discussion 757-794.
16. Flournoy T. Le cas de Charles Bonnet: hallucinations visuelles chez un vieillard opéré de la cataracte. Arch Psychol. (Geneva). 1902;1:1-23.
17. Naville E. Hallucinations visuelles a l'état normal. Arch Psychol. (Geneva). 1909;8:1-8, 200-206.
18. de Morsier G. Les hallucinations visuelles diencéphaliques. II. Psychiatr Clin (Basel). 1969;2:232-251.
19. Morax V. Sur les hallucinations visuelles survenant au cours des altérations rétiniennes. Progres Med. 1922;50:652-654.
20. Truc H. Phantopsies ou fantasmagories visuelles d'origine oculaire. Annales d'Oculist. 1925;162:649-655.
21. Brunerie A, Coche R. Sur trois cas d'hallucinations visuelles chez des cataractés. Ann Médico-Psychologiques. 1936;94:166-171.
22. Ormond AW. Visual hallucinations in sane people. BMJ. 1925;2:376-379.
23. Terson A. Hallucinations visuelles chex des ophtalmopathes. Annales d'Oculist. 1930;168:815-825.
24. de Morsier G. Réponses. Rev Oto-Neuro-Ophtalmol. 1939;17:218-240.
25. Hecaen H, Garcia Badaracco J. Les hallucinations visuelles au cours des ophthalmopathies et des lesions des nerfs et du chiasma optiques. L'Evolution Psychiat. 1956:157-179.
26. de Ajuriaguerra J, Garrone G. Désafférentation partielle et psychopathologie. In: de Ajuriaguerra J, edi. Désaffé rentation expérimentale et clinique. Geneva: Georg; 1965:91-157.
27. Burgermeister JJ, Tissot R, de Ajuriaguerra J. Les hallucinations visuelles des ophthalmopathes. Neuropsychologia. 1965;3:9-38.
28. de Morsier G. Le syndrome de Charles Bonnet: hallucinations visuelles des vieillards sans deficience mentale. Annales Medico-Psychologiques. 1967;125:677-702.
29. de Clérambault G. Du diagnostic différentiel des délires de cause chloralique. Ann Médico- Psychologiques. 1909;67:220-248; 365-389; 1910;68: 33-45; 192-215.
30. Société-Médico-Psychologique. Séance du 26 Avril 1909. Ann Médico-Psychologiques. 1909;67:58-59.
31. Leroy R. Les hallucinations lilliputiennes. Ann Médico-Psychologiques. 1909;67:278-289.
32. Leroy R. Un cas d'hallucinations lilliputiennes. Bull Société Clin Médecine Mentale. 1910:132-135.
33. Leroy R, Fursac Rd. Les hallucinations lilliputiennes. Encéphale. 1920;15:189-192.
34. Leroy R. Le syndrome des hallucinations lilliputiennes. Encéphale. 1921;16:504-510.
35. Leroy R. The syndrome of Lilliputian hallucinations. J Nerv Ment Dis. 1922;56:325-333.
36. Leroy R. The affective states in Lilliputian hallucinations. J Ment Sci. 1926;72:179-186.
37. Morel F. Hallucination et champ visuel. Ann Médico-Psychologiques. 1937;95:742-757.
38. Platz WE, Oberlaender FA, Seidel ML. The phenomenology of perceptual hallucinations in alcohol-induced delerium tremens. Psychopathology. 1995;28:247-255.
39. Fénelon G, Mahieux F, Huon R, Ziégler M. Hallucinations in Parkinson's disease: prevalence phenomenology and risk factors. Brain. 2000;123:733-745.
40. Weinberger LM, Grant FC. Visual hallucinations and their neuro-optical correlates. Arch Ophth Chicago. 1940;23:166-199.
41. Celesia GG. Positive spontaneous visual phenomena. In: Celesia G G, editor. Handbook of Clinical Neurophysiology: Disorders of Visual Processing. Elsevier; 2005:353-370.
42. Brown GC, Murphy RP. Visual symptoms associated with choroidal neovascularization. Photopsias and the Charles Bonnet syndrome. Arch Ophthalmol. 1992;110:1251-6.
43. Klüver H. Mescal and Mechanisms of Hallucinations. Chicago: University of Chicago Press, 1966.
44. Damas-Mora J, Skelton-Robinson M, Jenner FA. The Charles Bonnet Syndrome in perspective. Psychol Med. 1982;12:251-261.
45. Berrios GE, Brook P. The Charles Bonnet syndrome and the problem of visual perceptual disorders in the elderly. Age Ageing. 1982;11:17-23.
46. Berrios GE, Brook P. Visual hallucinations and sensory delusions in the elderly. Br J Psych. 1984;144:662-664.
47. Gold K, Rabins PV. Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation of six cases. Comprehensive Psychiatry. 1989;30:90-98.
48. Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: the Charles Bonnet Syndrome. Surv Ophthalmol. 2003;48:58-72.
49. Chapman FM, Dickinson J, McKeith I, Ballard C. Associations among visual hallucinations, visual acuity and specific eye pathologies in Alzheimer's disease. Am J Psychiatry. 1999;156:1983-1985.
50. Lance JW. Simple formed hallucinations confined to the area of a specific visual field defect. Brain. 1976;99:719-734.
51. Paulig M, Mentrup H. Charles Bonnet's syndrome: complete remission of complex visual hallucinations treated by gabapentin. J Neurol Neurosurg Psychiatry. 2001;70:813-814.
52. Burke WJ, Roccaforte WH, Wengel SP. Treating visual hallucinations with donepezil. Am J Psychiatry. 1999;156:1117-1118.
53. Zoldan J, Friedberg G, Livneh M, Melamed E. Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist. Neurology. 1995;45:1305-1308.
54. Ranen NG, Pasternak RE, Rovner BW. Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome. Am J Geriatr Psychiatry. 1999;7:264-266.
55. Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology 2000;55:1588-1589.
56. Zeki S, ffytche DH. The Riddoch syndrome: insights into the neurobiology of conscious vision. Brain. 1998;121:25-45.
57. Moutoussis K, Zeki S. The relationship between cortical activation and perception investigated with invisible stimuli. Proc Natl Acad Sci U S A. 2002;99:9527-9532.
58. Pins D, ffytche DH. The neural correlates of conscious vision. Cereb Cortex 2003;13:461-474.
59. Block N. Two neural correlates of consciousness. Trends Cogn Sci. 2005;9:46-52.
60. ffytche DH, Howard RJ, Brammer MJ, David A, Woodruff P, Williams S. The anatomy of conscious vision: an fMRI study of visual hallucinations. Nature Neurosci. 1998;1:738-742.
61. Adachi N, Watanabe T, Matsuda H, Onuma T. Hyperperfusion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations: single photon emission computed tomography findings in patients with Charles Bonnet syndrome. Psychiatry Clin Neurosci. 2000;54:157-62.
62. ffytche DH, Howard RJ. The perceptual consequences of visual loss: positive pathologies of vision. Brain. 1999;122:1247-1260.
63. Zeki S, Watson JDG, Frackowiak RSJ. Going beyond the information given: the relation of illusory visual motion to brain activity. Proc R Soc Lon B. 1993;252:215-222.
64. ffytche DH, Zeki S. Brain activity related to the perception of illusory contours. Neuroimage. 1996;3:104-108.
65. Heo K, Cho YJ, Lee SK, Park SA, Kim KS, Lee BI. Single-photon emission computed tomography in a patient with ictal metamorphopsia. Seizure. 2004;13:250-253.
66. Tootell RBH, Reppas JB, Dale AM, et al. Visual motion aftereffect in human cortical area MT revealed by functional magnetic resonance imaging. Nature. 1995;375:139-141.
67. Nunn JA, Gregory LJ, Brammer M et al. Functional magnetic resonance imaging of synesthesia: activation of V4/V8 by spoken words. Nat Neurosci. 2002;5:371-375.
68. Braun AR, Balkin TJ, Wesenten NJ et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain. 1997;120(Pt 7):1173-1197.
69. Howard RJ, ffytche DH, Barnes J, et al. The functional anatomy of imagining and perceiving colour. Neuroreport. 1998;9:1019-1023.
70. Ganis G, Thompson WL, Kosslyn SM. Brain areas underlying visual mental imagery and visual perception: an fMRI study. Brain Res Cogn Brain Res. 2004;20:226-241.
71. Mechelli A, Price CJ, Friston KJ, Ishai A. Where bottom-up meets top-down: neuronal interactions during perception and imagery. Cereb Cortex. 2004;14:1256-1265.
72. Dixon MJ, Smilek D, Merikle PM. Not all synaesthetes are created equal: projector versus associator synaesthetes. Cogn Affect Behav Neurosci. 2004;4:335-343.
73. Binkofski F, Amunts K, Stephan KM et al. Broca's region subserves imagery of motion: a combined cytoarchitectonic and fMRI study. Hum Brain Mapp. 2000;11:273-285.
74. Santhouse AM, Howard RJ, ffytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain. 2000;123:2055-2064.
75. Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AI, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet. 1996;347:794-797.
76. Kölmel HW. Coloured patterns in hemianopic fields. Brain. 1984;107:155-167.
77. Kölmel HW. Complex visual hallucinations in the hemianopic field. J Neurol Neurosurg Psychiatry. 1985;48:29-38.
78. Vaphiades MS, Celesia GG, Brigell MG. Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology. 1996;47:408-417.
79. Cogan DG. Visual hallucinations as release phenomena. Graefe's Archiv Clin Exp Opthalmol. 1973;188:139-50.
80. Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry 2002;73:535-541.
81. Holroyd S, Rabins PV, Finkelstein D, Nicholson MC, Chase GA, Wisniewski SC. Visual hallucinations in patients with macular degeneration. Am J Psych. 1992;149:1701-1706.
82. Teunisse RJ, Cruysberg JR, Verbeek AL, Zitman FG. The Charles Bonnet syndrome: a large prospective study in the Netherlands. Br J Psychiatry. 1995;166:254-257.
83. Scott IU, Schein OD, Feuer WJ, Folstein MF. Visual hallucinations in patients with retinal disease. Am J Ophthalmol. 2001;131:590-598.
84. Barnes J, David AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry. 2001;70:727-33.
85. Graham JM, Grünewald RA, Sagar HJ. Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;63:434-440.
86. Holroyd S, Sheldon-Keller A. A study of visual hallucinations in Alzheimer's disease. Am J Geriatric Psychiatry. 1995;3:198-205.
87. Ballard C, McKeith I, Harrison R et al. A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer's disease. Int Psychogeriatr. 1997;9:381-388.
88. Mosimann UP, Rowan EN, Partington CE, et al. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies. Am J Geriatr Psychiatry. 2006;14:153-160.
89. Benke T. Peduncular hallucinosis: A syndrome of impaired reality monitoring. J Neurol. 2006:253:1561-1571.
90. Perry EK, Perry RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cognition. 1995;28:240-258.
91. Abraham HD. Visual phenomenology of the LSD flashback. Arch Gen Psychiatry. 1983;40:884-889.
92. Halpern JH, Pope HG, Jr. Hallucinogen persisting perception disorder: what do we know after 50 years? Drug Alcohol Depend. 2003;69:109-119.
93. Schilder P. The vestibular apparatus in neurosis and psychosis. J Nerv Ment Dis. 1933;78:1-23;137-164.
94. Liu GT, Schatz NJ, Galetta SL, Volpe NJ, Skobieranda F, Kosmorsky GS. Persistent positive visual phenomena in migraine. Neurology. 1995;45:664-668.
95. Klee A, Willanger R. Disturbances of visual perception in migraine. Acta Neurologica Scandinavica. 1966;42:400-414.
96. McGuire PK, Cope H, Fahy T. Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy'). Br J Psych. 1994;165:391-395.
97. Ihde-Scholl T, Jefferson JW. Mirtazapine-associated palinopsia. J Clin Psychiatry. 2001;62:373.